StockDrifts LogoStockDrifts

BVF Inc Il 13F Portfolio

Portfolio Manager
Bvf INC Il
Performance
+29.26% (2026 Q2)
AUM (13F)
$3.91B
# of Holdings
44
Performance Rank
Allocation (Top 20)
87%
Latest filing
Q2 2026

Bvf INC Il Holdings Map

Top 41 Bvf INC Il Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
RVMD
REVOLUTION MEDICINES INC
14.2%2.97M$555.3M
+3.79%(+108.38K)
2025-Q2: 4.98M shares2025-Q3: 3.97M shares2025-Q4: 3.36M shares2026-Q1: 2.86M shares2026-Q2: 2.97M shares
$34.56(+521.02%)
2026-06-30
KYMR
KYMERA THERAPEUTICS INC
11.35%3.87M$444.0M
-29.63%(-1.63M)
2025-Q2: 5.50M shares2025-Q3: 5.50M shares2025-Q4: 5.50M shares2026-Q1: 5.50M shares2026-Q2: 3.87M shares
$33.88(+246.51%)
2026-06-30
XOMA
XOMA ROYALTY CORPORATION
8.25%7.59M$322.7M
+193.14%(+5.00M)
2025-Q2: 2.59M shares2025-Q3: 2.59M shares2025-Q4: 2.59M shares2026-Q1: 2.59M shares2026-Q2: 7.59M shares
$29.28(+37.19%)
2026-06-30
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
7.97%16.00M$311.5M
+0.00%(+0)
2025-Q2: 19.75M shares2025-Q3: 19.75M shares2025-Q4: 19.75M shares2026-Q1: 16.00M shares2026-Q2: 16.00M shares
$7.63(+116.79%)
2026-06-30
GHRS
GH RESEARCH PLC
5.95%8.65M$232.5M
+0.00%(+0)
2025-Q2: 8.83M shares2025-Q3: 8.83M shares2025-Q4: 8.83M shares2026-Q1: 8.65M shares2026-Q2: 8.65M shares
$20.24(+45.73%)
2026-06-30
GPCR
STRUCTURE THERAPEUTICS INC
4.62%3.37M$180.7M
-2.67%(-92.53K)
2025-Q2: 1.77M shares2025-Q3: 3.20M shares2025-Q4: 3.48M shares2026-Q1: 3.46M shares2026-Q2: 3.37M shares
$31.93(+70.02%)
2026-06-30
NKTR
NEKTAR THERAPEUTICS
4.27%2.39M$166.9M
-6.58%(-168.52K)
2025-Q2: 0 shares2025-Q3: 1.28M shares2025-Q4: 1.56M shares2026-Q1: 2.56M shares2026-Q2: 2.39M shares
$48.43(+52.51%)
2026-06-30
MIRM
MIRUM PHARMACEUTICALS INC
3.16%1.06M$123.6M
-33.36%(-528.70K)
2025-Q2: 2.76M shares2025-Q3: 1.50M shares2025-Q4: 1.50M shares2026-Q1: 1.58M shares2026-Q2: 1.06M shares
$31.95(+215.00%)
2026-06-30
XNCR
XENCOR INC
2.94%7.13M$114.9M
+0.00%(+0)
2025-Q2: 2.74M shares2025-Q3: 2.74M shares2025-Q4: 7.13M shares2026-Q1: 7.13M shares2026-Q2: 7.13M shares
$16.06(+45.32%)
2026-06-30
ALKS
ALKERMES PLC
2.89%2.15M$112.9M
+7.74%(+154.70K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 2.00M shares2026-Q2: 2.15M shares
$32.36(+51.61%)
2026-06-30

About Bvf INC Ilโ€™s portfolio

Bvf INC Il reports $3.91B in US-listed equity holdings across 44 positions in its most recent 13F filing. Its largest disclosed positions are RVMD (14.2%), KYMR (11.3%) and XOMA (8.3%). The top 20 holdings account for 87% of reported assets. Its disclosed equity book has returned +83.21% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
RVMD โ€” 14.3% ($555.32M)KYMR โ€” 11.4% ($444.01M)XOMA โ€” 8.3% ($322.72M)MLTX โ€” 8.0% ($311.54M)GHRS โ€” 6.0% ($232.52M)GPCR โ€” 4.6% ($180.70M)NKTR โ€” 4.3% ($166.92M)MIRM โ€” 3.2% ($123.63M)XNCR โ€” 2.9% ($114.85M)ALKS โ€” 2.9% ($112.90M)Other โ€” 34.1% ($1.33B)
66%in top 10
  • RVMD14.3%
  • KYMR11.4%
  • XOMA8.3%
  • MLTX8.0%
  • GHRS6.0%
  • GPCR4.6%
  • NKTR4.3%
  • MIRM3.2%
  • XNCR2.9%
  • ALKS2.9%
  • Other34.1%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
4
QTTBQ32 BIO INC0.8%
ABSIABSCI CORPORATION0.7%
SGMTSAGIMET BIOSCIENCES INC0.5%
ENTXENTERA BIO LTD0.1%
Added to
6
XOMAXOMA ROYALTY CORPORATION+193.1%
RVMDREVOLUTION MEDICINES INC+3.8%
AVTXAVALO THERAPEUTICS INC+27.1%
ALKSALKERMES PLC+7.7%
+2 more
Trimmed
8
KYMRKYMERA THERAPEUTICS INC-29.6%
MIRMMIRUM PHARMACEUTICALS INC-33.4%
PVLAPALVELLA THERAPEUTICS INC NE-30.0%
TYRATYRA BIOSCIENCES INC-25.3%
+4 more

Unlock alerts, watchlists & AI chat

Sign up free to track Bvf INC Il, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Bvf INC Ilโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1056807). View Bvf INC Ilโ€™s 13F filings on SEC

More 13F analyses

View all